Please Wait
Applying Filters...
menu
    • menu
    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Bedaquiline

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,526Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Phase 2 Trial Reveals Potential To Reduce TB Treatment Duration
    Phase 2 Trial Reveals Potential To Reduce TB Treatment Duration

    19 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phase-2-clinical-trial-results-show-potential-to-shorten-tb-treatment-time-302619952.html

    PR NEWSWIRE
    19 Nov 2025
    Share Share
    Plans to Restrict Open Market Access to Tuberculosis Medicines
    Plans to Restrict Open Market Access to Tuberculosis Medicines

    27 Jun 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/plans-to-restrict-open-market-access-to-tuberculosis-medicines/articleshow/122098065.cms

    ECONOMICTIMES
    27 Jun 2025
    Share Share
    J&J Reduces Sirturo Price In South Africa, Ending Antitrust Probe
    J&J Reduces Sirturo Price In South Africa, Ending Antitrust Probe

    09 Jul 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/jj-agrees-40-price-cut-tuberculosis-med-sirturo-south-africa-ending-antitrust-probe

    FIERCE PHARMA
    09 Jul 2024
    Share Share
    J&J's tuberculosis Sirturo lands full US, EU approvals
    J&J's tuberculosis Sirturo lands full US, EU approvals

    08 Jul 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/jjs-tuberculosis-med-sirturo-lands-full-us-european-approvals-after-more-decade

    FIERCE PHARMA
    08 Jul 2024
    Share Share
    Janssen Submits Phase 3 Study Data to the EMA and FDA for SIRTURO
    Janssen Submits Phase 3 Study Data to the EMA and FDA for SIRTURO

    07 Nov 2023

    // PRESS RELEASE

    https://www.jnj.com/janssen-submits-phase-3-study-data-to-the-european-medicines-agency-and-u-s-food-and-drug-administration-for-sirturo-bedaquiline

    PRESS RELEASE
    07 Nov 2023
    Share Share
    After pubic pressure, J&J says it won't enforce Sirturo patents
    After pubic pressure, J&J says it won't enforce Sirturo patents

    02 Oct 2023

    // Zoey Becker FIERCE PHARMA

    https://www.fiercepharma.com/pharma/johnson-johnson-commits-not-enforce-secondary-patents-tuberculosis-med-sirturo

    Zoey Becker FIERCE PHARMA
    02 Oct 2023
    Share Share